United States · FDA National Drug Code directory
IRBESARTAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-439_2efa4733-b806-42ee-b587-cae816493fa7
- Product NDC
- 46708-439
- Form
- TABLET
- Composition / generic term
- IRBESARTAN
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160701
- Source listing expiry
- 20261231
Source-listed ingredients
- IRBESARTAN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (46708-439-30) · 46708-439-30
- 100 TABLET in 1 BOTTLE (46708-439-31) · 46708-439-31
- 500 TABLET in 1 BOTTLE (46708-439-71) · 46708-439-71
- 90 TABLET in 1 BOTTLE (46708-439-90) · 46708-439-90
- 1000 TABLET in 1 BOTTLE (46708-439-91) · 46708-439-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →